Company: PSTV
Filing Date: 2025-08-14
Form Type: 8-K
Source: 0001193125-25-180814
Chunk: 1

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-08-14
Form: 8-K
Item: Item 8.01
Chunk 1
---
 Listing Rule 5550(b)(2) (the “ Alternative MVLS Requirement”), for 20 consecutive business days. In accordance with Nasdaq Listing Rule 5810(c)(3)(C), Nasdaq will only render a determination regarding MVLS compliance once an issuer has evidenced compliance with the MVLS threshold for a minimum of ten, though generally not more than 20, consecutive business days. The Company awaits Nasdaq’s formal confirmation that the Company has satisfied either or both the Equity Rule and the Alternative MVLS Requirement.